AviPro 442 ND-IB2-BTO2-REO

Company: Elanco US

BURSAL DISEASE-NEWCASTLE DISEASE-BRONCHITIS-REOVIRUS VACCINE

STANDARD AND VARIANT

MASS. AND ARK. TYPES, KILLED VIRUS

FOR USE IN ANIMALS ONLY

This product has been shown to be effective for the vaccination of healthy chickens 16 weeks of age or older against Newcastle disease, infectious bronchitis (Mass. and Ark. types) and the AL-2 variant of infectious bursal disease, and to provide passive protection of progeny against reovirus-related malabsorption syndrome and tenosynovitis, and type 1 infectious bursal disease, standard and variant strains. Duration of immunity has not been established for this product. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. Protection of progeny against the AL-2 variant has not been demonstrated.

Directions For Use

Vaccine should be warmed to room temperature before use. Shake well before and during use.

Inject subcutaneously.

Vaccinate (prime) with live virus vaccines for infectious bursal disease, Newcastle disease, infectious bronchitis and tenosynovitis at least 4 weeks prior to the use of this vaccine. Vaccinate between 16 and 20 weeks of age.

A revaccination schedule has not been established for this product; consultation with a veterinarian is recommended.

Dose: 1/2 mL (0.5 mL) per bird. Inject all birds in flock.

Contains penicillin and streptomycin as preservatives.

Storage temperature: Store at 2° to 8°C (35° to 46°F). Do not freeze.

Warnings

In case of human exposure, contact a physician. Do not vaccinate within 42 days before slaughter. Use entire contents when first opened. Do not mix with other products, except as specified on the label.

Manufactured in the USA by: Elanco US Inc., Winslow, Maine 04901 USA

Phone 1-800-428-4441

VLN/PCN 196/12M5.42

AviPro, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2021 Elanco or its affiliates.

CPN: 1008089.6